Search Results for 'Paladin, Apeiron in Neuroblastoma Pact'
Refine by Dates:
Refine By Content:
Published January 17, 2013
Paladin granted rights to market APN311 in Canada and Africa Read More »
By Chris Landeg, Director of Business Development
By Tom Patnaik, Director of Sales & MArketing
Please visit our sister sites: